EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced large-scale production and purification of recombinant human NUPR1 for detailed structural and functional insights

Minsu Kim, Joonhyeok Choi, Hae-Kap Cheong, Kyoung-Seok Ryu, Jin-Wan Park, Jung-Hye Ha, Jong-Soo Lim, Woo Sung Son, Sangwook Wu, Donghan Lee

Protein Expression and Purification · 2026-09 · 242 · 106940

DOI: 10.1016/j.pep.2026.106940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Expression and Purification, 2026-09. Verfasst von Minsu Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Protein Structure and Drug Mechanism Research, Korea Basic Science Institute, Ochang-Eup, Cheongju-Si, 28119, Republic of Korea; Novorex I…. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Proteins, Neoplasm Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Daegu-Gyeongbuk Medical Innovation Foundation, Korea Basic Science Institute, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nuclear Protein 1 (NUPR1) is a critical modulator of numerous cellular processes, including cell cycle regulation, apoptosis, and oncogenic transformation. Its structural characterization is indispensable for understanding its multifaceted biological functions and for its validation as a potential therapeutic target in diseases. Although foundational studies have reported on the expression and purification of NUPR1, detailed and scalable protocols for large-scale production, a prerequisite for advanced biophysical techniques such as Nuclear Magnetic Resonance (NMR) spectroscopy, have remained largely unarticulated. This study describes a successfully developed, optimized, and scalable protocol for the high-yield production and purification of recombinant human NUPR1. This optimized protocol consistently yielded 2-3 mg of NUPR1 per liter of M9 minimal medium with greater than 95% purity and high monodispersity, as confirmed by SEC-MALS analysis, making it highly suitable for demanding structural biology applications. Furthermore, efficient isotopic labeling strategies incorporating 15N and 13C were successfully implemented, enabling detailed multi-dimensional NMR spectroscopic analysis. Preliminary NMR data, including backbone resonance assignments, unequivocally confirmed the intrinsically disordered nature of NUPR1. Secondary structure propensity analysis derived from these assignments indicated a characteristically low propensity for the formation of stable canonical secondary structures. This robust, well-characterized, and scalable expression and purification pipeline provides an essential and solid foundation for future detailed structural, dynamic, and functional investigations of NUPR1, which are crucial for dissecting its complex roles in cellular physiology and disease pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic Helix-Loop-Helix ProteinsNeoplasm ProteinsHumansRecombinant ProteinsNuclear Magnetic Resonance, BiomolecularEscherichia coliCloning, Molecular

Substanzen

NUPR1 protein, humanRecombinant ProteinsBasic Helix-Loop-Helix ProteinsNeoplasm Proteins

Autor:innen und Institutionen

  • Center for Protein Structure and Drug Mechanism Research, Korea Basic Science Institute, Ochang-Eup, Cheongju-Si, 28119, Republic of Korea; Novorex Inc., 240 Pangyoyeok-Ro, Seongnam-Si, Gyeonggi-Do, 13493, Republic of K…
  • Center for Protein Structure and Drug Mechanism Research, Korea Basic Science Institute, Ochang-Eup, Cheongju-Si, 28119, Republic of Korea; Department of Applied Pharmacy, College of Pharmacy, Chungbuk National Universi…
  • Center for Protein Structure and Drug Mechanism Research, Korea Basic Science Institute, Ochang-Eup, Cheongju-Si, 28119, Republic of Korea.
  • Center for Protein Structure and Drug Mechanism Research, Korea Basic Science Institute, Ochang-Eup, Cheongju-Si, 28119, Republic of Korea; Department of Convergent Analytical Science, University of Science and Technolo…
  • New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDI hub), 80 Cheombok-ro, Dong-gu, Daegu, 41061, Republic of Korea.
  • Novorex Inc., 240 Pangyoyeok-Ro, Seongnam-Si, Gyeonggi-Do, 13493, Republic of Korea.

Förderung

  • Daegu-Gyeongbuk Medical Innovation Foundation
  • Korea Basic Science Institute
  • National Research Foundation of Korea

Zitieren

APA

Kim, M., Choi, J., Cheong, H. K., Ryu, K. S., Park, J. W., Ha, J. H., Lim, J. S., Son, W. S., Wu, S., & Lee, D. (2026). Enhanced large-scale production and purification of recombinant human NUPR1 for detailed structural and functional insights. Protein Expression and Purification, 242, 106940. https://doi.org/10.1016/j.pep.2026.106940

Vancouver

Kim M, Choi J, Cheong HK, Ryu KS, Park JW, Ha JH, et al. Enhanced large-scale production and purification of recombinant human NUPR1 for detailed structural and functional insights. Protein Expression and Purification. 2026;242:106940. doi:10.1016/j.pep.2026.106940

BibTeX
@article{Kim2026,
  author = {Kim, Minsu and Choi, Joonhyeok and Cheong, Hae-Kap and Ryu, Kyoung-Seok and Park, Jin-Wan and Ha, Jung-Hye and Lim, Jong-Soo and Son, Woo Sung and Wu, Sangwook and Lee, Donghan},
  title = {Enhanced large-scale production and purification of recombinant human NUPR1 for detailed structural and functional insights},
  journal = {Protein Expression and Purification},
  year = {2026},
  volume = {242},
  pages = {106940},
  doi = {10.1016/j.pep.2026.106940}
}
Kostenlos starten →